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Abstract
Background: Although, in South Korea, human immunodeficiency virus/acquired immunodeficiency syndrome
(HIV/AIDS) keeps increasing and tuberculosis(TB) burden is still significant, there have been few reports on TB/HIV
cases. In this study, we investigated the burden and characteristics of TB/HIV patients in South Korea, an area with
intermediate burden of TB and a low prevalent area with HIV/AIDS.
Methods: We identified patients with TB and cases with HIV between January 1 2001 and December 31 2005,
from nationwide reporting system (TBnet and HIV/AIDS registry) through an electronic record linkage method. A
questionnaire survey was also conducted and determined the rate of diagnosis of HIV among TB cases in public
health units in 2005.
Results: The number of cases with both HIV and TB was 137 (0.07% among 197,562 TB cases) and the newly
detected TB/HIV cases per 100,000 population was increasing annually: 2001, 0.025; 2002, 0.031; 2003, 0.025; 2004,
0.071; 2005, 0.095. Males between 20 and 59 years of age accounted for 87.6% of TB/HIV patients. Compared with
patients with TB alone, those with TB/HIV had a higher percentage of extrapulmonary TB (8.0% vs 19.0%; p <
0.0001). The standardized prevalence ratio (SPR) of HIV among patients with TB was 18.46 (95% CI, 15.50-21.83). SPR
of HIV among male TB patients aged 20-59 and extrapulmonary TB cases was 39.64 (95% CI, 32.87-47.40) and 43.21
(95% CI, 28.22-63.31) respectively. Through a questionnaire survey of public health units, six patients (0.08%) were
confirmed as having HIV among 7,871 TB patients in public health centers in 2005, which is similar to the result
from the study through nationwide reporting systems.
Conclusions: The prevalence rate of TB/HIV patients is still low but increasing in South Korea. Physicians should
consider performing HIV tests among TB patients, especially in higher-risk groups, such as young males with
extrapulmonary TB in South Korea.
Background
Tuberculosis (TB) and human immunodeficiency virus/
acquired immunodeficiency syndrome (HIV/AIDS) are
mankind’s major infectious diseases [1,2]. Comorbidity
with HIV and TB has been highlighted recently. It is well
known that TB and HIV are closely associated. HIV infec-
tion contributes to the progression from a recently
acquired [3] or latent [4] TB infection to the active form
of the disease. HIV infection also increases the risk of
recurrence of TB [5]. In addition, the relationship between
HIV and drug-resistant TB, including extensively drug
resistant (XDR) TB, is cause for concern [6-8]. Conversely,
it has been reported that TB may also promote infection
[9] with HIV and progression to AIDS [10,11].
According to the World Health Organization, the
number of TB cases among HIV-infected people was 0.7
million in 2006, [1] which is significant because HIV is
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sub-Saharan Africa [12]. It was also reported that treat-
ment of latent TB infection could also prevent TB
development in TB/HIV cases [13]. In addition, early
detection and intervention for HIV among TB cases are
also emphasized [14,15]. The World Health Organiza-
tion stressed that HIV prevention should be a priority
for strategies aimed at controlling TB [16] and that all
TB patients should be offered HIV counseling and test-
ing [1,17]. However, there could be controversies,
because screening tests for HIV have a high rate of
false-positive results in countries with low prevalence
rate with HIV/AIDS [18]. In addition, how many TB
patients underwent HIV testing and how many HIV/
AIDS cases were detected among them in individual
countries including South Korea has not been fully
investigated [19].
It was reported that HIV/AIDS cases have increased in
South Korea since the first case was identified in 1985,
in spite of the low prevalence rate under 0.01% [20,21].
Although results from seven nationwide prevalence sur-
veys at five-yearly intervals from 1965 to 1995 revealed
a significant decrease in the prevalence of TB [22],
South Korea is still regarded as a country with inter-
mediate TB burden; however, studies on the burden and
characteristics of TB/HIV cases in South Korea has
been rarely reported [1]. The purposes of this study
were to document the burden and characteristics of TB/
HIV patients in Korea, which is an area with low HIV/
AIDS prevalence [2] and a country with an intermediate
TB burden [1], and to evaluate the contribution of HIV
testing among TB patients, by using linkage of national
registries, and a survey of public health centers (PHC).
Methods
Data sources
The population database for this study consists of three
components: Korea TB Surveillance System (KTBS)
data, the national registry data of patients with HIV/
AIDS (the HIV/AIDS national registry), and data from
Korea National Statistical Office (KNSO). In South
Korea, the TB prevention law requires doctors to notify
regional public health centers of all cases of TB (In the
study, TB refers to ‘active TB disease’). Additionally,
patients suspicious for having HIV infection (for exam-
ple, cases with positive anti-HIV antibody testing)
undergo confirmatory diagnostic testing using the Wes-
tern blot method at government institutes and all people
diagnosed with HIV/AIDS are registered for monitoring.
We used the KTBS and the HIV/AIDS national registry
to identify people who were diagnosed with HIV/AIDS
and TB between 1 January 2001 and 31 December 2005.
Comorbidity with HIV/AIDS and TB was verified by
identifying patients who hadb e e nr e g i s t e r e db o t hi n
KTBS and HIV/AIDS national registry using an electro-
nic record linkage method with Standard Query Lan-
guage (SQL) procedure with SAS version 9.1 (SAS
Institute, NC, USA). The year of comorbidity was deter-
mined to be the year when the later infection between
TB and HIV/AIDS was diagnosed. Demographic data
for 2003 were obtained from the KNSO. [23] and were
used to characterize the general population at the mid-
point between 2001 and 2005. A questionnaire survey
was conducted among managers of PHC, which are
infrastructures of Korean public health care system, to
determine the number of HIV screening tests conducted
among TB patients and the rate of diagnosis of HIV in
2005. This study was not submit to an ethics institu-
tional review board as the data we used for this study is
existing data including a questionnaire survey that parti-
cipants cannot be identified, and the dataset is already
reviewed by some authorities of Korea Center for
Disease Control and Prevention (KCDC) and Korean
Institute of Tuberculosis (KIT).
Statistical analyses
We characterized demographic data according to age/
age group (0-9, 10-19, 20-29, 30-39, 40-49, 50-59, ≥ 60
years of age), sex, date of HIV diagnosis, date of initial
anti-TB treatment, CD4+ lymphocyte cell count (data
was expressed as median with interquartile range (IQL)
upon diagnosis of HIV, and type of TB from the data of
population database.
To compare the prevalence rates of HIV infection
among TB patients and HIV/AIDS infection among the
general Korean population, standardized prevalence
ratios (SPRs) [24,25] that were adjusted by sex and age
were calculated as:
SPR standardized  prevalence ratio the observed prevale () (  n nt number
the expected prevalent number
)/
() 
The expected number of people with HIV was extra-
polated from the prevalence rate of HIV among the sur-
vivors of the general population at 30
th June, 2003 (the
midpoint of the study), which was based on the register
of HIV/AIDS and the KNSO. For example, ‘SPR of HIV
is 5.0 at male TB group’ means that the number of
observed HIV cases is 5.0 times more than the expected
number of HIV cases calculated from the prevalence
rate in the general population of men.
The statistical analyses were carried out using the SQL
procedures in SAS version 9.1, STATA version 10.1
(StataCorp, Tex, USA) and Microsoft Excel and Power-
point program (Microsoft, WA, USA)
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The total number of patients with HIV/AIDS between
1st January, 2001 and 31th December, 2005 was 2,548.
Of these, 92.4% were male. The median age was 37
years (range, 4-80 years). The peak age group was 30-39
years of age (34.3% of all patients). The annual number
of newly detected HIV/AIDS cases per 100,000 people
increased with time: 2001, 0.69; 2002, 0.84; 2003, 1.11;
2004, 1.27; 2005, 1.41. The average increasing rate of
cases with HIV was 19.6% per year (Figure 1). CD4+
lymphocyte cell counts were available for 1,466 patients
(57.5% of all confirmed HIV/AIDS patients). The med-
ian CD4+ lymphocyte cell count was 315.0 cells/mm
3
(IRQ, 186.0-464.0).
The total number of patients with TB from 1st Janu-
ary, 2001 to 31th December, 2005 was 197,562. Of
these, 62.9% were male. The median age was 44 years
(range, 0-97 years). Of those less than 60 years of age,
the peak age group was 20-29 years old (20.1% of all
patients with TB). Most patients had pulmonary TB
(92%, including patients with positive sputum smears
[36.4%]) and 8% had extrapulmonary TB. The most
common type of extrapulmonary TB was TB pleurisy
(3.4% of all patients with TB). (Table 1)
There were 137 TB/HIV patients between 2001 and
2005, and 96.4% of these were male. The median age
was 39 years (range, 19-79 years). The peak age group
was 30-39 years (37.2% of all patients), and males aged
20-59 accounted for 87.6% of the total TB/HIV cases.
Annual newly detected TB/HIV cases per 100,000 popu-
lation increased with time (p < 0.001): 2001, 0.025;
2002, 0.031; 2003, 0.025; 2004, 0.071; 2005, 0.095. (Fig-
ure 1). Among the patients with TB, 0.07% had HIV
and 5.4% of the HIV/AIDS patients contracted TB. The
number of HIV/AIDS patients who were subsequently
diagnosed with TB was greater than the number of
patients with TB who subsequently were diagnosed with
HIV. The median time interval before HIV patients
were registered with TB was 199 days (range, 3-1,455
days); the median time interval before TB patients were
diagnosed with HIV was 20 days (range, 1-1,140 days).
For patients with comorbidity, the median CD4+ lym-
phocyte cell count upon diagnosis of HIV was 301.0
cells/mm
3. There was no significant difference in the
CD4+ lymphocyte cell count at diagnosis of HIV
between patients with HIV alone and patients coinfected
with TB and HIV (p = 0.587 by Mann-Whitney U test).
There was no significant difference in the CD4 count at
diagnosis of HIV between TB patients who subsequently
contracted HIV and HIV patients who subsequently
contracted TB (median CD4+ lymphocyte cell count,
316.5 cells/mm
3 vs. 268.0 cells/mm
3; p = 0.706 by
Mann-Whitney U test). Compared with patients with
TB alone, those with comorbidity had a higher percen-
tage of extrapulmonary TB (OR, 2.69; 95% CI, 1.75-4.12;
p < 0.0001) and similar percentage of sputum smear
positivity among pulmonary TB (OR, 0.93; 95% CI, 0.63-
1.37; p = 0.715). The most common type of extrapul-
monary TB in comorbid patients was TB lymphadenitis
(7.3% of all coinfection cases) (Table 1).
The SPR of HIV among overall TB patients was 18.46
(95% CI, 15.50-21.83). SPR of HIV among male aged
20-59 was 39.64 (95% CI, 32.87-47.40), while SPR of
HIV among male aged ≤ 19 or ≥ 60 and among female
was 7.33 (95% CI, 3.78-12.81) and 7.87 (95% CI, 2.54-
18.37), respectively. SPR of HIV among cases with extra-
pulmonary TB was 43.21 (95% CI, 28.22-63.31), while
SPR of HIV among cases with pulmonary TB and
Figure 1 The trends of newly detected HIV infection cases and TB/HIV cases in South Korea (2001-2005).
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19.38) and 15.40 (95% CI, 11.10-20.82), respectively.
(Table 2)
In 2005, HIV screening tests were performed on 7,871
(60.4%) of the 13,028 TB patients (27.7% of total noti-
fied cases) registered with PHC in South Korea. Of
these, six patients (0.08%), five of whom were male,
were confirmed as having HIV.
Discussion
Our study showed that the number of TB/HIV patients
was increasing but the percentage of HIV-infected TB
patients was low (0.07%) in Korea. The results of ques-
tionnaire surveys conducted at PHC were similar (0.08%
of TB patients was infected with HIV).
The annual number of HIV patients increased by
15.8% per year between 2001 and 2005. Although the
prevalence rate of patients with TB has decreased in
Korea during the last four decades, [22] the number of
TB patients notified was constant or has even increased
during the five years of our study period [26]. As the
prevalence rate of HIV/AIDS increases, the number of
TB patients may also increase because the peak age for
HIV and that of TB overlap considerably. For example,
in our study, 51.8% of patients with TB, 79.8% of people
living with HIV/AIDS, and 81.0% of TB/HIV patients
w e r eb e t w e e n2 0a n d4 9y e a r so fa g e .I nr e g i o n sw i t h
intermediate-to-high burden TB, it is a common finding
that the incidence rate of TB is high in young age
groups [27,28]. Although there are other key important
issues resulting in TB/HIV comorbidity including over-
lapping risk factors for the transmission of the two dis-
eases such as intravenous drug use [29], which is rarely
attributable to transmission of both diseases in South
Korea, given that (1) TB is prevalent in young age
groups which is probably due to recent infection in
regions with intermediate TB burden, (2) HIV/AIDS
infection, in which the immune system destruction is
Table 1 Characteristics of patients with HIV, patients with TB, and patients with coinfection of TB and HIV in Korea
(2001-2005).
HIV (N = 2,548) TB (N = 197,562) HIV & TB (N = 137)
Sex, male : female 2,355(92.4%):193(7.6%) 124,183(62.9%):73,379(37.1%) 132(96.4%):5(3.6%)
Age, median (range) 37.0 (4-80) 44 (0-97) 39.5 (19.9-79.1)
0-9 2 (0.1%) 1,000 (0.5%) 0 (0%)
10-19 60 (2.4%) 12,575 (6.4%) 1 (0.7%)
20-29 576 (22.6%) 39.638 (20.1%) 19 (13.9%)
30-39 873 (34.3%) 32,231 (16.3%) 51 (37.2%)
40-49 583 (22.9%) 30,515 (15.4%) 41 (29.9%)
50-59 318 (12.5%) 23,206 (11.7%) 14 (10.2%)
60- 136 (5.3%) 58,397 (29.6%) 11 (8.0%)
Year Cases Incidence
(cases/10
5)
Cases Incidence
(cases/10
5)
Cases Incidence
(cases/10
5)
2001 327 0.69 42,737 90.3 17 0.036
2002 398 0.84 38,801 81.4 20 0.042
2003 534 1.11 36,227 75.6 21 0.044
2004 610 1.27 36,041 74.8 40 0.083
2005 680 1.41 43,781 90.7 39 0.081
CD4 count at diagnosis, median(IQR) (/mm
3) 315.0 (186.0-464.0) 301.0 (171.5-460.0)
TB type (% among patients with TB)
Pulmonary 183,640 (92.0%) 111 (81.0%)
Smear positive 72,599 (36.4%) 42 (30.7%)
Extrapulmonary 16,021 (8.0%) 26 (19.0%)
Pleurisy 6,852 (3.4%) 3 (2.2%)
Lymphnode 3,675 (1.8%) 10 (7.3%)
Gastrointestinal 1,797 (0.9%) 5 (3.6%)
Nervous 657 (0.3%) 3 (2.2%)
Skin 272 (0.1%) 1 (0.7%)
Other organs 2,169 (1.1%) 1 (0.7%)
Disseminated 599 (0.3%) 3 (2.2%)
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concentrated in similar age groups and would be an
obstacle in TB control in young age, and (3) if TB in
young ages were not controlled properly, the future bur-
den of TB would still be substantial because of reactiva-
tion in older ages from the latent TB infection,
overlapping age in both diseases might be a potential
threat of TB control in South Korea.
The percentage of HIV infection among TB patients
(0.07%) is significantly higher, especially among some
subgroups, than that among general population in South
Korea (0.06%). The SPRs of HIV infection among
patients with TB (18.46) were relatively high, which
indicated that the risks of having HIV among TB
patients were more than 18 times greater than that of
the general population. This was comparable to the
results of previous studies [27,30,31]. The proportion of
HIV infection (0.07%) among TB patients notified in
South Korea between 2001-2005, and the proportion of
HIV infection (0.08%) diagnosed by screening test
among TB patients of PHC in 2005 in our study are
also much greater than the prevalence rate of HIV
among general Korean population in 2005, which was
6.4 cases per 100,000 population (0.006%). Therefore,
HIV screening of TB patients may be worthwhile in set-
tings such as ours. In addition, we wondered if the low
prevalence rate of comorbidity with HIV could indicate
TB patients with a high risk of HIV infection should be
selected for HIV testing. Knowledge of the epidemiolo-
gical characteristics of patients with comorbidity, which
is affected by the prevalence rate of TB and HIV and
the route of transmission of HIV infection, would be
helpful [27,29,32,33]. In our study, most patients with
TB/HIV were young males, who were mainly caused by
this group having a higher sexual activity and being at
the peak age for HIV. Most patients acquired HIV by
sexual contact (more than 98% of all patients [20]),
including a relatively high proportion of homosexual
contact with HIV-infected persons (reported as 40%
[20], but estimated as more than 50%; data not shown)
in South Korea. Patients with comorbidity tended to
have a greater proportion of extrapulmonary TB than
did patients with TB alone. Among patients with pul-
monary TB, those infected with HIV had a lower rate of
positive sputum smears than did those with TB alone,
although statistical significance could not be demon-
strated in our cohort. This result agrees with that of a
previous report, which showed that, in patients with
HIV/AIDS, especially in the late stage of HIV infection,
TB is often atypical in presentation, frequently causes
extrapulmonary disease, and has low sputum smear
positivity in pulmonary TB, which could result in
delayed diagnosis of TB [34]. In our study, SPR of HIV
among males aged 20-59 was very high as 39.64, while
SPR of HIV among male aged ≤ 19 or ≥ 60 and among
female was 7.33 and 7.87. SPR of HIV among cases with
extrapulmonary TB was 43.21, however, SPR of HIV
among cases with pulmonary TB and among smear-
positive TB was also 16.09 and 15.40 respectively,
although those SPRs were smaller than that among
extrapulmonary TB cases. Based on our results, we
recommend that physicians should consider performing
Table 2 SPR of HIV among overall cases with TB.
Subgroup No. of TB cases No. of HIV cases PR 95% CI
Observed* Expected Lower Upper
By sex
Male 124,183 132 8.21 16.09 13.46 19.08
Female 73,379 5 0.65 7.87 2.54 18.37
By age
0-9 1,000 0 0.00 0.00 NA 7,800.11
10-19 12,575 1 0.03 34.87 NA 193.99
20-29 39,638 19 1.48 12.84 7.73 20.05
30-39 32,231 51 2.44 20.92 15.57 27.50
40-49 30,515 41 1.98 20.75 14.89 28.16
50-59 23,206 14 1.11 12.58 6.87 21.12
60- 58,397 11 1.02 10.79 5.38 19.30
Male aged 20-59 80,599 120 3.03 39.64 32.87 47.40
Male aged < 19 or ≥ 60 43,584 12 1.64 7.33 3.78 12.81
Pulmonary TB 183,640 111 6.90 16.09 13.24 19.38
Smear-positive TB 72,599 42 2.73 15.40 11.10 20.82
Extrapulmonary TB 16,021 26 0.60 43.21 28.22 63.31
Overall 197,562 85 7.42 18.46 15.50 21.83
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Page 5 of 7HIV tests among patients with TB, especially males aged
20-59 and those with extrapulmonary TB in South
Korea. However, we could not completely disagree to
the recommendation that all TB patients should
undergo HIV testing (universal approach) [1,17] because
the SPRs of HIV among other groups such as pulmon-
ary TB cases were not low. In our study, if only male
TB patients between age 20 and 59 had undergone HIV
testing, 17 cases (12.4% of comorbid cases) with TB/
HIV could be missed. On the other hand, if HIV screen-
ing were restricted to male TB patients aged 20-59 or
patients with extrapulmonary TB, 11 cases (8.0% of
comorbid cases) could be missed. The guideline of
South Korea recommends all TB patients should
undergo HIV testing now.
It could also be thought that the high SPR of HIV
among patients with TB suggests that TB increases the
risk of contracting HIV, which was, to our knowledge,
the first clinical suggestion. Some researchers reported
that patients with TB have increased expression of co-
receptors for HIV, increased levels of proinflammatory
cytokines, and down-regulated RANTES(Regulated upon
Activation, Normal T-cell Expressed, and Secreted),
which increase susceptibility to HIV infection [9]. TB
could also be a sentinel diagnosis which prompted
investigation for HIV in these patients. However, this
suggestion cannot be concluded in our study, consider-
ing that we could not ascertain whether HIV could have
preceded TB or could have been detected simulta-
neously with TB in some patients.
There were some limitations in our study. First, as
KTBS includes only TB patients who were notified [35],
the data could not reflect all TB patients in South
Korea. In addition, although HIV/AIDS national registry
includes all confirmed HIV/AIDS cases, there can be
many undiagnosed HIV/AIDS cases. However, given
that the survey conducted in PHC showed 0.08% of TB
patients were diagnosed as comorbidity with HIV by
HIV screening test, which is similar to the result of
database data (0.07% among TB cases registered in
KTBS had also be registered in HIV/AIDS registry), it
was considered that our study sample could represent
real life situation although there is no evidence that pri-
vate and public units similarly follow the national
recommendations. Second, although our survey sup-
ported the prevalence rate of TB/HIV cases from the
population database data, it was not possible to compare
cases within subgroups because the number of comorbid
cases in the survey was too small: There were only six
cases.
Conclusions
The burden of HIV and TB/HIV is still low in South
Korea, which is a low prevalent area with HIV/AIDS
and a country with intermediate TB burden. However,
the increase in the number of HIV patients could be a
potential threat to TB control in South Korea. In addi-
tion, it is recommended that physicians should consider
performing HIV tests among TB patients, especially in
higher-risk groups, such as young males with extrapul-
monary TB in South Korea.
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